MedTrace Logo

Non-Interventional Study About Treatment of Hemorrhages in Thyroid Surgery With TachoSil®

NCT00700141 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 482

Last updated 2012-05-08

Study results available
· View outcomes & findings →

Summary

Considering the total number of thyroid procedures in Germany (100000 - 120000 cases per year), TachoSil® is a valuable tool to support surgical haemostasis, avoiding lymph leaks and support speech-nerve saving approaches. The aim of this study was to evaluate a patient and procedure profile where TachoSil® is most beneficial.

Conditions

Sponsors & Collaborators

  • Nycomed

    lead INDUSTRY

Principal Investigators

  • Dr. Thomas D. Bethke, MD, MBA · Nycomed Deutschland GmbH, 78467 Konstanz, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00700141 on ClinicalTrials.gov